Inhibitors of dihydrofolate reductase as antitumor agents: design, synthesis and biological evaluation of a series of novel nonclassical 6-substituted pyrido[3,2-d]pyrimidines with a three- to five-carbon bridge.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2018-05-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmc.2018.04.035PMID 29691154
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Host dihydrofolate reductase (DHFR)-directed cycloguanil analogues endowed with activity against influenza virus and respiratory syncytial virus

  2017cited by this paper
• Design, Synthesis, and Biological Evaluation of Coupled Bioactive Scaffolds as Potential Anticancer Agents for Dual Targeting of Dihydrofolate Reductase and Thioredoxin Reductase.

  2017cited by this paper
• Synthesis and antiproliferative activity of a series of novel 6-substituted pyrido[3,2-d]pyrimidines as potential nonclassical lipophilic antifolates targeting dihydrofolate reductase.

  2017cited by this paper
• Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity.

  2016cited by this paper
• Structure-activity correlations for three pyrido[2,3-d]pyrimidine antifolates binding to human and Pneumocystis carinii dihydrofolate reductase.

  2015cited by this paper
• Nonclassical antifolates, part 5. Benzodiazepine analogs as a new class of DHFR inhibitors: synthesis, antitumor testing and molecular modeling study.

  2014cited by this paper
• The folate receptor as a rational therapeutic target for personalized cancer treatment.

  2014cited by this paper
• Nonclassical antifolates, part 3: synthesis, biological evaluation and molecular modeling study of some new 2-heteroarylthio-quinazolin-4-ones.

  2013cited by this paper
• The proton-coupled folate transporter: physiological and pharmacological roles.

  2013cited by this paper
• The antifolates.

  2012cited by this paper
• Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance.

  2012cited by this paper
• Mechanism-based design, synthesis and biological studies of N⁵-substituted tetrahydrofolate analogs as inhibitors of cobalamin-dependent methionine synthase and potential anticancer agents.

  2012cited by this paper
• Synthesis and evaluation of 8-deaza-5,6,7,8-tetrahydromethotrexate derivatives as dihydrofolate reductase inhibitors

  2012cited by this paper
• Antifolate inhibitors of thymidylate synthase as anticancer drugs.

  2010cited by this paper
• The antifolates: evolution, new agents in the clinic, and how targeting delivery via specific membrane transporters is driving the development of a next generation of folate analogs.

  2010cited by this paper
• Antimitotic chalcones and related compounds as inhibitors of tubulin assembly.

  2009cited by this paper
• Colloidal Palladium Nanoparticles with In Situ H2: Reducing System for α,β-Unsaturated Carbonyl Compounds

  2009cited by this paper
• The effect of 5-alkyl modification on the biological activity of pyrrolo[2,3-d]pyrimidine containing classical and nonclassical antifolates as inhibitors of dihydrofolate reductase and as antitumor and/or antiopportunistic infection agents.

  2008cited by this paper
• Molecular basis of antifolate resistance

  2007cited by this paper
• Human reduced folate carrier: translation of basic biology to cancer etiology and therapy

  2007cited by this paper
• Eukaryotic dihydrofolate reductase.

  2006cited by this paper
• Antifolate Resistance in a HeLa Cell Line Associated With Impaired Transport Independent of the Reduced Folate Carrier

  2004cited by this paper
• Functional analysis of altered reduced folate carrier sequence changes identified in osteosarcomas.

  2004cited by this paper
• Loss of folylpoly‐γ‐glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation‐dependent novel antifolates in multiple human leukemia sublines

  2003cited by this paper
• Anticancer antifolates: current status and future directions.

  2003cited by this paper
• 10-propargyl-10-deazaaminopterin: an antifolate with activity in patients with previously treated non-small cell lung cancer.

  2003cited by this paper
• Inhibition of epidermal growth factor receptor tyrosine kinase by chalcone derivatives.

  2001cited by this paper
• ADDRESSING THE UNUSUAL REACTIVITY OF 2-PYRIDINECARBOXALDEHYDE AND 2-QUINOLINECARBOXALDEHYDE IN BASE-CATALYZED ALDOL REACTIONS WITH ACETOPHENONE

  1998cited by this paper
• Improved efficiency and selectivity in peptide synthesis: Use of triethylsilane as a carbocation scavenger in deprotection of t-butyl esters and t-butoxycarbonyl-protected sites

  1992cited by this paper
• Immunohistochemistry of dihydrofolate reductase in methotrexate-sensitive and -resistant human cell lines by flow cytometry: a comparison with the cytochemical tetrazolium salt method.

  1992cited by this paper
• Novel pyrrolo[2,3-d]pyrimidine antifolates: synthesis and antitumor activities.

  1991cited by this paper
• The renewed potential for folate antagonists in contemporary cancer chemotherapy.

  1991cited by this paper
• ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study.

  1991cited by this paper
• Readily accessible 12-I-5 oxidant for the conversion of primary and secondary alcohols to aldehydes and ketones

  1983cited by this paper
• Pyridopyrimidines. 12. Synthesis of 8-deaza analogs of aminopterin and folic acid

  1981cited by this paper
• Carbon-carbon Bond Formation

  1979cited by this paper

• Synthesis, in vitro biological evaluation and in silico studies of novel pyrrolidine derived thiosemicarbazones as dihydrofolate reductase inhibitors

  2024cites this paper
• Design, synthesis, in vitro and in silico studies of novel piperidine derived thiosemicarbazones as inhibitors of dihydrofolate reductase

  2024cites this paper
• Design and one-pot synthesis of new substituted pyrrolo[1,2-a]thieno[3,2-e]pyrimidine as potential antitumor agents: in vitro and in vivo studies.

  2024cites this paper
• Synthesis, antitumor activities and functional mechanism of purine derivatives harboring phenyl moieties through three carbon bridges

  2023cites this paper
• Medicinal chemistry perspective of pyrido[2,3-d]pyrimidines as anticancer agents

  2023cites this paper
• Dihydrofolate reductase inhibitors: patent landscape and phases of clinical development (2001–2021)

  2022cites this paper
• Breast Cancer Treatment: The Case of Gold(I)-Based Compounds as a Promising Class of Bioactive Molecules

  2022cites this paper
• Human dihydrofolate reductase inhibition effect of 1-Phenylpyrazolo[3,4-d]pyrimidines: Synthesis, antitumor evaluation and molecular modeling study.

  2022cites this paper
• New quinazolinone‐based derivatives as DHFR/EGFR‐TK inhibitors: Synthesis, molecular modeling simulations, and anticancer activity

  2022cites this paper
• Synthesis, Antitumor Activity, and In Silico Drug Design of New Thieno[2,3-d]Pyrimidine-4-One Derivatives as Nonclassical Lipophilic Dihydrofolate Reductase Inhibitors

  2022cites this paper
• Targeted Mitochondrial Fluorescence Imaging-Guided Tumor Antimetabolic Therapy with the Imprinted Polymer Nanomedicine Capable of Specifically Recognizing Dihydrofolate Reductase.

  2021cites this paper
• An Insight into Synthetic Strategies and Recent Developments of Dihydrofolate Reductase Inhibitors

  2021cites this paper
• A Review of Small-Molecule Inhibitors of One-Carbon Enzymes: SHMT2 and MTHFD2 in the Spotlight.

  2021cites this paper
• The advances of methotrexate resistance in rheumatoid arthritis

  2020cites this paper
• DHFR Inhibitors: Reading the Past for Discovering Novel Anticancer Agents

  2019cites this paper
• Dihydrofolate reductase inhibition effect of 5-substituted pyrido[2,3-d]pyrimidines: Synthesis, antitumor activity and molecular modeling study.

  2019cites this paper
• Targeting dihydrofolate reductase: Design, synthesis and biological evaluation of novel 6-substituted pyrrolo[2,3-d]pyrimidines as nonclassical antifolates and as potential antitumor agents.

  2019cites this paper
• Recent Design and Structure-Activity Relationship Studies on Modifications of DHFR Inhibitors as Anticancer Agents.

  2019cites this paper